Table S1: Inclusion and exclusion criteria for clinical studies. Table S2: Primer sequences and NCBI accession numbers. Table S3: Characterisitcs of matched subgroups. Table S4: Indications for open abdominal surgery. Table S5: Correlation of chemerin with clinical and paraclinical parameters in the first study cohort. Table S6: Correlation of chemerin with clinical and paraclinical parameters in second cohort
Is Table S1 presenting diagnoses in patients admitted with sepsis by infection likelihood. Overview ...
Table S1. Dysregulated cytokines and specific autoimmune diseases included in the studyâs autoimmu...
Table S1. Central line characteristics. Description of type, location, and insertion duration of cen...
Figure S3. Correlation of fasting and intra-operative glucose levels with circulating chemerin in T2...
Figure S2. Correlation of fasting and intra-operative glucose levels with circulating chemerin in co...
Characteristics of enzyme-linked immunosorbent assays for plasma proteins. Table S2. Patient charact...
Is presenting results analyzed using a nonimputed data set. *Adjusted for demographics, health behav...
No. of patients, age, BMI, length of PICU stay, Body temperature, PRISM III, group (“0” for conventi...
Figure S1. Missing rate for clinical and laboratory variables extracted from the database. Variables...
Figure S2. (AâD) In-hospital mortality. Serum and urinary levels of calprotectin, Cystatin C, GDF-...
Supplementary tables. Table S1. Results of quality assessment of included studies using Newcastle-Ot...
Table S1. Comparison of comorbidities between patients with infection and sepsis developing in the f...
Table S1. Prospective multicenter cohort studies (noninterventional) among patients with severe seps...
Table S2. Summary of outcomes for the effect of Terlipressin in septic shock patients. (DOCX 21 kb
Table S1. Characteristics of patients by typicality of cholecystitis symptoms. Table S2. Characteris...
Is Table S1 presenting diagnoses in patients admitted with sepsis by infection likelihood. Overview ...
Table S1. Dysregulated cytokines and specific autoimmune diseases included in the studyâs autoimmu...
Table S1. Central line characteristics. Description of type, location, and insertion duration of cen...
Figure S3. Correlation of fasting and intra-operative glucose levels with circulating chemerin in T2...
Figure S2. Correlation of fasting and intra-operative glucose levels with circulating chemerin in co...
Characteristics of enzyme-linked immunosorbent assays for plasma proteins. Table S2. Patient charact...
Is presenting results analyzed using a nonimputed data set. *Adjusted for demographics, health behav...
No. of patients, age, BMI, length of PICU stay, Body temperature, PRISM III, group (“0” for conventi...
Figure S1. Missing rate for clinical and laboratory variables extracted from the database. Variables...
Figure S2. (AâD) In-hospital mortality. Serum and urinary levels of calprotectin, Cystatin C, GDF-...
Supplementary tables. Table S1. Results of quality assessment of included studies using Newcastle-Ot...
Table S1. Comparison of comorbidities between patients with infection and sepsis developing in the f...
Table S1. Prospective multicenter cohort studies (noninterventional) among patients with severe seps...
Table S2. Summary of outcomes for the effect of Terlipressin in septic shock patients. (DOCX 21 kb
Table S1. Characteristics of patients by typicality of cholecystitis symptoms. Table S2. Characteris...
Is Table S1 presenting diagnoses in patients admitted with sepsis by infection likelihood. Overview ...
Table S1. Dysregulated cytokines and specific autoimmune diseases included in the studyâs autoimmu...
Table S1. Central line characteristics. Description of type, location, and insertion duration of cen...